Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics is still responsible for an $8.3 million award to a patient who claimed the companies were responsible for injuries caused by recalled hip implants.
Metal-on-Metal
DePuy Pinnacle lawsuits: Judge orders J&J’s DePuy Orthopaedics to produce compliance reports
Hip implants: Johnson & Johnson’s DePuy will stop selling metal-on-metal implants
Johnson & Johnson (NYSE:JNJ) is pulling the plug on its troubled metal-on-metal hip implant business, effective August 31.
Hips: Bellwether federal trial against DePuy delayed
The 1st trial representing a multi-district complaint against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics was delayed by court order, now slated to begin in June.
Legal: DePuy aims to reverse $8.3M metal hip implant loss
Johnson & Johnson (NYSE:JNJ) and its DePuy Orthopaedics subsidiary are hoping to dodge an $8.3 million judgment stemming from the company’s 1st metal-on-metal hip implant complaint to go to trial.
Johnson & Johnson lands jury’s favor in 2nd metal-on-metal hip lawsuit
A Chicago jury this week jury ruled in favor of healthcare giant Johnson & Johnson (NYSE:JNJ), rejecting a patient’s claims that the company was liable for injuries she allegedly sustained after receiving the metal-on-metal ASR XL hip implant.
Former FDA official testifies on behalf of DePuy in metal hip implant lawsuit
A former FDA official told jurors this week that Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics followed proper federal guidelines in monitoring its now-recalled metal-on-metal hip implants.
J&J faces 2nd trial in in recalled hip controversy | MassDevice.com On Call
MASSDEVICE ON CALL — Healthcare giant Johnson & Johnson (NYSE:JNJ) denied claims this month in the 2nd of tens of thousands of patient injury lawsuits over its implanted metal-on-metal hips.
FLASH: Jury deems J&J’s DePuy ASR XL hip implant defective in design, orders $8.3M in damages
A California jury ruled against Johnson & Johnson (NYSE:JNJ) and its DePuy subsidiary in finding that the company’s ASR XL metal-on-metal hip implant was defectively designed.
Closing arguments in DePuy ASR lawsuit
Johnson & Johnson (NYSE:JNJ) ignored serious problems with its DePuy ASR metal-on-metal hip implant in a game of "Russian roulette" the company played with patients’ safety, a plaintiff’s lawyer in a high-profile personal injury lawsuit said during the case’s closing arguments yesterday.
Regulators probe J&J’s marketing of recalled hip implants
Federal investigators recently launched an additional inquiry into Johnson & Johnson (NYSE:JNJ) and its DePuy Orthopaedics subsidiary, taking a closer look at marketing practices surrounding a line of recalled metal-on-metal hips.